New immune therapies combined with complementary-oncology measures… together, we are stronger!

Rupert Handgretinger

Rupert Handgretinger

New immune therapies combined with complementary-oncology measures
… together, we are stronger!

Ben Pfeifer, Rupert Handgretinger

© 2018 Aeskulap International AG, Switzerland
Department of Hematology/Oncology, University Hospital Tübingen, Germany

New-immune-therapies-combined-with-complementary-oncology-measures-BPF-RH

More publications from Rupert Handgretinger

Removal of CD276+ cells from haploidentical memory T-cell grafts significantly lowers the risk of GVHD

Bernd Landmann2021-11-06T07:41:22+01:00Categories: Other article for therapists|Tags: Rupert Handgretinger|

New immune therapies combined with complementary-oncology measures… together, we are stronger!

Bernd Landmann2021-11-05T20:29:09+01:00Categories: Other article for therapists|Tags: Rupert Handgretinger|

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation

Bernd Landmann2021-11-06T08:12:49+01:00Categories: Other article for therapists|Tags: Rupert Handgretinger|

131Iodine-GD2-ch14.18 scintigraphy to evaluate option for radioimmunotherapy in patients with advanced tumors

Bernd Landmann2021-11-06T08:20:06+01:00Categories: Other article for therapists|Tags: Rupert Handgretinger|

Bernd Landmann2021-11-05T20:29:09+01:00November 5, 2021|Other article for therapists|